Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
3.
Hepatogastroenterology ; 48(42): 1625-7, 2001.
Article in English | MEDLINE | ID: mdl-11813587

ABSTRACT

Local pancreatic resection and enucleation have the advantage of preserving pancreatic parenchyma but pancreatic fistula often occurs postoperatively. We describe a case in which preoperative endoscopic pancreatic stenting prevented pancreatic fistula formation following local pancreatic resection. A pancreatic stent seems to prevent leakage from small pancreatic branch ducts not identified or ligated intraoperatively, via the pancreatic decompression effect. The present case demonstrates a novel indication for endoscopic pancreatic stenting.


Subject(s)
Carcinoma, Pancreatic Ductal/surgery , Pancreatectomy , Pancreatic Fistula/prevention & control , Pancreatic Neoplasms/surgery , Stents , Carcinoma, Pancreatic Ductal/pathology , Cholangiopancreatography, Endoscopic Retrograde , Endosonography , Female , Humans , Middle Aged , Pancreatic Neoplasms/pathology , Preoperative Care
4.
J Biochem ; 126(3): 457-60, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10467159

ABSTRACT

The functional effects of two missense mutations in human cardiac troponin T, Phe110Ile and Glu244Asp, associated with familial hypertrophic cardiomyopathy were examined by exchanging the bacterially expressed and purified mutant troponin T into rabbit cardiac skinned muscle fibers. Both mutations significantly increased the maximum force without affecting the cooperativity. The Glu244Asp mutation also increased the Ca(2+) sensitivity of the force generation, as in the case of other mutations associated with a poor prognosis. On the other hand, the Phe110Ile mutation, associated with a favorable prognosis, had no effect on the Ca(2+) sensitivity. The results strongly support the hypothesis that increased Ca(2+) sensitivity is responsible for the pathogenesis of hypertrophic cardiomyopathy with a poor prognosis caused by mutations in troponin T.


Subject(s)
Muscle Fibers, Skeletal/physiology , Mutation, Missense , Myocardium/metabolism , Troponin T/physiology , Animals , Aspartic Acid/chemistry , Aspartic Acid/genetics , Base Sequence , Calcium/metabolism , Cardiomyopathy, Hypertrophic/genetics , Cardiomyopathy, Hypertrophic/physiopathology , DNA Primers , Glutamic Acid/chemistry , Glutamic Acid/genetics , Humans , Isoleucine/chemistry , Isoleucine/genetics , Male , Phenylalanine/chemistry , Phenylalanine/genetics , Rabbits , Troponin T/chemistry , Troponin T/genetics
5.
Am J Physiol ; 277(2): C225-32, 1999 08.
Article in English | MEDLINE | ID: mdl-10444398

ABSTRACT

A splice donor site mutation in intron 15 of the cardiac troponin T (TnT) gene has been shown to cause familial hypertrophic cardiomyopathy (HCM). In this study, two truncated human cardiac TnTs expected to be produced by this mutation were expressed in Escherichia coli and partially (50-55%) exchanged into rabbit permeabilized cardiac muscle fibers. The fibers into which a short truncated TnT, which lacked the COOH-terminal 21 amino acids because of the replacement of 28 amino acids with 7 novel residues, had been exchanged generated a Ca(2+)-activated maximum force that was slightly, but statistically significantly, lower than that generated by fibers into which wild-type TnT had been exchanged when troponin I (TnI) was phosphorylated by cAMP-dependent protein kinase. A long truncated TnT simply lacking the COOH-terminal 14 amino acids had no significant effect on the maximum force-generating capability in the fibers with either phosphorylated or dephosphorylated TnI. Both these two truncated TnTs conferred a lower cooperativity and a higher Ca(2+) sensitivity on the Ca(2+)-activated force generation than did wild-type TnT, independent of the phosphorylation of TnI by cAMP-dependent protein kinase. The results demonstrate that the splice donor site mutation in the cardiac TnT gene impairs the regulatory function of the TnT molecule, leading to an increase in the Ca(2+) sensitivity, and a decrease in the cooperativity, of cardiac muscle contraction, which might be involved in the pathogenesis of HCM.


Subject(s)
Cardiomyopathy, Hypertrophic/genetics , DNA, Recombinant , Mutation/physiology , Troponin T/genetics , Troponin T/physiology , Animals , Calcium/physiology , Cardiomyopathy, Hypertrophic/physiopathology , Cyclic AMP-Dependent Protein Kinases/metabolism , Humans , Male , Myocardial Contraction/physiology , Peptide Fragments/genetics , Peptide Fragments/physiology , Rabbits , Troponin I/metabolism
6.
Biochem Biophys Res Commun ; 261(1): 79-82, 1999 Jul 22.
Article in English | MEDLINE | ID: mdl-10405326

ABSTRACT

A carboxyl terminal missense mutant Arg278Cys of human cardiac troponin T that causes familial hypertrophic cardiomyopathy was expressed in Escherichia coli, purified, and exchanged into rabbit cardiac skinned muscle fibers using a troponin exchange technique. Compared to the fibers exchanged with human cardiac wild-type troponin T, the fibers exchanged with the mutant Arg278Cys developed less maximum force with a decreased cooperativity and a slightly increased Ca(2+) sensitivity, resulting in a significant elevation of sub-half-maximal force. Since intact cardiac muscle is thought to never be activated beyond the half-maximum level, the results suggest that an enhanced myofilament response to Ca(2+) may be responsible for the pathogenesis of hypertrophic cardiomyopathy associated with this mutation. The results also provide the first evidence that the carboxyl terminal region of cardiac troponin T plays an important role probably through its interaction with tropomyosin in allowing troponin complex to inhibit the muscle contraction at low Ca(2+), in agreement with the hypothesis deduced from the previous studies on fast skeletal troponin T.


Subject(s)
Muscle Contraction , Muscle Fibers, Skeletal/physiology , Mutation, Missense , Myocardium/cytology , Troponin T/metabolism , Actin Cytoskeleton/drug effects , Actin Cytoskeleton/physiology , Amino Acid Substitution , Animals , Calcium/pharmacology , Cardiomyopathy, Hypertrophic/genetics , Escherichia coli/genetics , Humans , In Vitro Techniques , Muscle Contraction/drug effects , Muscle Fibers, Fast-Twitch/physiology , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/metabolism , Protein Isoforms , Rabbits , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Troponin T/biosynthesis , Troponin T/genetics , Troponin T/isolation & purification
7.
Chirality ; 10(4): 349-57, 1998.
Article in English | MEDLINE | ID: mdl-9614690

ABSTRACT

Stereoselectivity in the renal secretion of carbenicillin (CBPC) was studied in rabbits. Significant renal secretion of CBPC was observed in vivo, with the secretion of the S-epimer being greater than that of the R-epimer. Stereoselective transport of CBPC was further studied in vitro using basolateral and brush border membrane vesicles prepared from rabbit kidneys. The transport of CBPC by the organic anion transporter into the basolateral membrane vesicles (BLMV) was not stereoselective. In contrast, a distinct stereoselectivity was observed in the transport of CBPC by the organic anion transporter into the brush border membrane vesicles (BBMV), with the transport of the S-epimer being more favorable. Significant epimer-epimer interactions were also observed in the transport into BBMV. The stereoselectivity of the transport of CBPC was calculated from the kinetic parameters with consideration of epimer-epimer interactions and was similar to that observed in vivo. It was concluded that the observed stereoselectivity in the renal secretion of CBPC in vivo reflected that of transport via the organic anion transporter located at the brush border membrane.


Subject(s)
Carbenicillin/metabolism , Kidney/metabolism , Microvilli/metabolism , Penicillins/metabolism , Animals , Anions/metabolism , Biological Transport , Carbenicillin/pharmacokinetics , Kidney/ultrastructure , Penicillins/pharmacokinetics , Rabbits
8.
Biopharm Drug Dispos ; 19(4): 251-8, 1998 May.
Article in English | MEDLINE | ID: mdl-9604125

ABSTRACT

The renal secretion of carbenicillin (CBPC) was studied in rats. The results obtained in the in vivo study indicated very poor renal secretion of CBPC in rats, which was entirely different from those observed in humans and rabbits. In humans and rabbits, significant and stereoselective renal secretion of CBPC was observed in vivo. In order to verify the poor renal secretion of CBPC in rats, the transport characteristics of the organic anion transporters were studied in vitro using basolateral and brush border membrane vesicles. Transport of p-aminohippuric acid (PAH) into the basolateral membrane vesicles (BLMVs) was inhibited by CBPC, indicating that the organic anion transporter located at the BLM may have affinity to CBPC. In contrast, the transport of PAH into the brush border membrane vesicles (BBMVs) was not inhibited by CBPC, suggesting that the organic anion transporter located at the BBM may not have affinity to CBPC. Similar results were obtained for sulbenicillin (SBPC). Since CBPC and SBPC exist as di-anions at physiological pH, the organic anion transporter located at the rat renal BBM may not exhibit affinity to water-soluble di-anions, which in turn will result in poor renal secretion of these compounds.


Subject(s)
Carbenicillin/metabolism , Carrier Proteins/metabolism , Kidney/metabolism , Kidney/ultrastructure , Penicillins/metabolism , Animals , Anion Transport Proteins , Carbenicillin/blood , Carbenicillin/pharmacokinetics , Male , Microvilli/metabolism , Penicillins/blood , Penicillins/pharmacokinetics , Rats , Rats, Sprague-Dawley , p-Aminohippuric Acid/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...